Erlotinib Induced Trichomegaly of the Eyelashes.
- Author:
Sang Hoon JEON
1
;
Jeong Seon RYU
;
Gwang Seong CHOI
;
Jung Soo KIM
;
Hea Yoon KWON
;
Min Su KIM
;
Hae Seong NAM
;
Jae Hwa CHO
;
Seung Min KWAK
;
Hong Lyeol LEE
;
Hyun Jung KIM
;
Geun Jeong HONG
Author Information
- Publication Type:Case Report
- Keywords: Receptor, Epidermal Growth Factor; Erlotinib; Lung Neoplasms; Eyelashes; Physiological Effects of Drugs
- MeSH: Adenocarcinoma; Cosmetics; Eyelashes; Female; Humans; Lung; Lung Neoplasms; Physiological Effects of Drugs; Protein-Tyrosine Kinases; Quinazolines; Receptor, Epidermal Growth Factor; Erlotinib Hydrochloride
- From:Tuberculosis and Respiratory Diseases 2013;74(1):37-40
- CountryRepublic of Korea
- Language:English
- Abstract: Epithelial growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for non-small-cell lung cancer patients. Its untoward cutaneous effects are largely well known and developed in many patients treated with EGFR TKIs. However trichomegaly of eyelash is rarely reported. Although trichomegaly is not a drug-limiting side effect, it could be troublesome of continuing the treatment because of cosmetic issue or eyeball irritation by long eyelashes. Therefore clinicians are needed to pay attention to this uncommon effect. We herein describe erlotinib induced trichomegaly of eyelashes in a woman with adenocarcinoma of the lung.
